% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Moraitis:298597,
author = {A. Moraitis$^*$ and T. Kahl$^*$ and J. Kandziora$^*$ and W.
Jentzen$^*$ and D. Kersting$^*$ and L. Püllen$^*$ and H.
Reis and J. Köllermann and C. Kesch$^*$ and U. Krafft$^*$
and B. A. Hadaschik$^*$ and H. Zaidi and K. Herrmann$^*$ and
F. Barbato$^*$ and W. P. Fendler$^*$ and C. Darr$^*$ and P.
Fragoso Costa$^*$},
title = {{E}valuation of {S}urgical {M}argins with {I}ntraoperative
{PSMA} {PET}/{CT} and {T}heir {P}rognostic {V}alue in
{R}adical {P}rostatectomy.},
journal = {Journal of nuclear medicine},
volume = {66},
number = {3},
issn = {0097-9058},
address = {New York, NY},
publisher = {Soc.},
reportid = {DKFZ-2025-00307},
pages = {352-358},
year = {2025},
note = {2025 Mar 3;66(3):352-358},
abstract = {Detection of positive resection margins in surgical
procedures of high-risk prostate cancer is key for
minimizing the risk of recurrence. This study aimed at
evaluating the accuracy of functional tumor-volume
segmentation in intraoperative ex vivo PET/CT for margin
assessment in prostate cancer patients undergoing radical
prostatectomy. Methods: Seven high-risk prostate cancer
patients received [18F]PSMA-1007 before radical
prostatectomy. After removal of the prostate gland, ex vivo
imaging on the AURA 10 PET/CT system was performed, and
functional tumor volume was segmented using 4 semiautomatic
segmentation methods. Resection margins and volumes were
compared with histopathology. Additionally, a supportive
phantom study was conducted to assess segmentation accuracy
at low radiopharmaceutical activity. Results: Clinically, 18
lesions were analyzed in intraoperative PET/CT. Sensitivity,
specificity, and positive and negative predictive values of
margin detection were $83\%,$ $100\%,$ $100\%,$ and $92\%,$
respectively, using an iterative thresholding method. In 1
patient, a biochemical recurrence was observed within 1 y of
prostate-specific antigen follow-up, and 1 patient underwent
adjuvant radiotherapy. The remaining 5 patients were still
undergoing prostate-specific antigen follow-up with no
evidence of biochemical recurrence. On the basis of a
phantom-deduced minimal segmentable activity concentration
of approximately 2 kBq/mL, we propose an administered
[18F]PSMA-1007 activity of at least 1.9 and 0.4 MBq/kg for
preoperative and intraoperative injections, respectively.
Conclusion: Intraoperative ex vivo PET/CT is a promising
modality for intraoperative margin assessment. Prospective
trials are needed to further investigate the value of
specimen PET/CT-based radioguided surgery in high-risk
prostate cancer.},
keywords = {PET/CT (Other) / margin assessment (Other) / prostate
cancer (Other) / radical prostatectomy (Other) / radioguided
surgery (Other)},
cin = {ED01},
ddc = {610},
cid = {I:(DE-He78)ED01-20160331},
pnm = {899 - ohne Topic (POF4-899)},
pid = {G:(DE-HGF)POF4-899},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:39915125},
doi = {10.2967/jnumed.124.268719},
url = {https://inrepo02.dkfz.de/record/298597},
}